These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 444479)

  • 21. Inactivation of S-adenosylhomocysteine hydrolase by 9-beta-D-arabinofuranosyladenine in intact cells.
    Helland S; Ueland PM
    Cancer Res; 1982 Mar; 42(3):1130-6. PubMed ID: 7059972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of chemotaxis by S-3-deazaadenosylhomocysteine in a mouse macrophage cell line.
    Aksamit RR; Falk W; Cantoni GL
    J Biol Chem; 1982 Jan; 257(2):621-5. PubMed ID: 7054170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of S-adenosylhomocysteine to hydroxyindole O-methyltransferase.
    Kuwano R; Takahashi Y
    Biochim Biophys Acta; 1984 May; 787(1):1-7. PubMed ID: 6722172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic AMP-adenosine binding protein/S-adenosylhomocysteinase from mouse liver. A fraction of adenosine bound is converted to adenine.
    Ueland M; Saebø J
    Biochim Biophys Acta; 1979 Jul; 585(4):512-26. PubMed ID: 223649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of S-adenosylhomocysteine hydrolase in adenosine metabolism in mammalian heart.
    Schrader J; Schütz W; Bardenheuer H
    Biochem J; 1981 Apr; 196(1):65-70. PubMed ID: 7306081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S-Aristeromycinyl-L-homocysteine, a potent inhibitor of S-adenosylmethionine-dependent transmethylations.
    Borchardt RT; Wu Y
    J Med Chem; 1976 Jan; 19(1):197-8. PubMed ID: 1246047
    [No Abstract]   [Full Text] [Related]  

  • 27. Contribution of S-adenosylhomocysteine to cardiac adenosine formation.
    Deussen A; Lloyd HG; Schrader J
    J Mol Cell Cardiol; 1989 Aug; 21(8):773-82. PubMed ID: 2778814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical and immunological evaluation of long term coformycin administration in the mouse.
    Lukey T; Snyder FF
    Adv Exp Med Biol; 1984; 165 Pt B():189-92. PubMed ID: 6720427
    [No Abstract]   [Full Text] [Related]  

  • 29. Disposition of homocysteine in rat hepatocytes and in nontransformed and malignant mouse embryo fibroblasts following exposure to inhibitors of S-adenosylhomocysteine catabolism.
    Svardal AM; Djurhuus R; Refsum H; Ueland PM
    Cancer Res; 1986 Oct; 46(10):5095-100. PubMed ID: 3756867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of S-adenosylhomocysteine in tissues following pharmacological inhibition of S-adenosylhomocysteine catabolism.
    Helland S; Ueland PM
    Adv Exp Med Biol; 1986; 195 Pt B():663-6. PubMed ID: 3490128
    [No Abstract]   [Full Text] [Related]  

  • 31. A radioisotope assay for 1-aminocyclopropane-1-carboxylic acid synthase: S-adenosylhomocysteine analogs as inhibitors of the enzyme involved in plant senescence.
    Miura GA; Chiang PK
    Anal Biochem; 1985 May; 147(1):217-21. PubMed ID: 4025819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of phosphoinositide metabolism in human polymorphonuclear leukocytes by S-adenosylhomocysteine.
    Pike MC; DeMeester CA
    J Biol Chem; 1988 Mar; 263(8):3592-9. PubMed ID: 2831194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocysteine enhances the inhibitory effect of extracellular adenosine on the synthesis of proteins in isolated rat hepatocytes.
    Tinton S; Buc-Calderon P
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):893-6. PubMed ID: 7575424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased rate of S-adenosyl-L-homocysteine metabolism: an early event related to transformation in cells infected with Rous sarcoma virus.
    Pierré A; Richou M; Lawrence F; Robert-Géro M; Vigier P
    Biochem Biophys Res Commun; 1977 Jun; 76(3):813-9. PubMed ID: 197927
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential effects on growth, homocysteine, and related compounds of two inhibitors of S-adenosylhomocysteine catabolism, 3-deazaadenosine, and 3-deazaaristeromycin, in C3H/10T1/2 cells.
    Djurhuus R; Svardal AM; Ueland PM
    Cancer Res; 1989 Jan; 49(2):324-30. PubMed ID: 2910451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
    Hershfield MS; Kredich NM; Koller CA; Mitchell BS; Kurtzberg J; Kinney TR; Falletta JM
    Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes.
    Bontemps F; Van den Berghe G; Hers HG
    Proc Natl Acad Sci U S A; 1983 May; 80(10):2829-33. PubMed ID: 6304684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding capacities of various analogues of S-adenosyl-L-homocysteine to protein methyltransferase II from human erythrocytes.
    Gillet L; Looze Y; Deconinck M; Léonis J
    Experientia; 1979 Aug; 35(8):1007-9. PubMed ID: 477857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in various tissues of mice given injections of 9-beta-D-arabinofuranosyladenine.
    Helland S; Ueland PM
    Cancer Res; 1983 Apr; 43(4):1847-50. PubMed ID: 6831422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of undermethylation on mRNA cytoplasmic appearance and half-life.
    Camper SA; Albers RJ; Coward JK; Rottman FM
    Mol Cell Biol; 1984 Mar; 4(3):538-43. PubMed ID: 6201720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.